logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9320773 B1

PDFFull Text
Expired
Date of Patent:
Apr. 26, 2016

Filed:

Aug. 04, 2011

Compounds and therapeutic applications related to inhibition of dendritic cell immunoreceptor (dcir) activity and signaling events

Applicants:

Caroline Gilbert, St-Augustin de Desmaures, CA;

Alexandra Lambert, Québec, CA;

Michel J. Tremblay, Québec, CA;

Inventors:

Caroline Gilbert, St-Augustin de Desmaures, CA;

Alexandra Lambert, Québec, CA;

Michel J. Tremblay, Québec, CA;

Assignee:

Université Laval, Québec, CA;

Attorneys:

Clark & Elbing LLP

Susan M. Michaud

Primary Examiner:

Marcela M Cordero Garcia

Assistant Examiner:

Mindy Newman

Int. Cl.
CPC ...
A61K 38/10 (2006.01); A61K 38/08 (2006.01); A61K 31/7088 (2006.01); C07K 14/705 (2006.01); C12N 15/113 (2010.01); G01N 33/50 (2006.01); G01N 33/569 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
A61K 38/10 (2013.01); A61K 31/7088 (2013.01); A61K 38/08 (2013.01); C07K 14/705 (2013.01); C12N 15/1137 (2013.01); C12Y 301/03048 (2013.01); G01N 33/5047 (2013.01); G01N 33/56988 (2013.01); A61K 38/00 (2013.01); C12N 2310/11 (2013.01); G01N 2333/16 (2013.01);
Abstract

The invention is concerned with methods, compounds and pharmaceutical compositions for interfering dendritic cell immunoreceptor (DCIR) activity and signalling events. Described herein are compounds useful in targeting one or more of intracellular modulators and the uses thereof for the prevention or treatment of virus infections, and more particularly for reducing human immunodeficiency virus (HIV) binding, entry and/or replication in human cells. Exemplary compounds include peptides and antisense molecules.

Find Patent Forward Citations

Gilbert, Caroline. (2016). Compounds and therapeutic applications related to inhibition of dendritic cell immunoreceptor (dcir) activity and signaling events (U.S. Patent No. 9320773). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/9320773

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…